Astra C
Withdrawn from the US market on 7 August 2025 (according to the DSLD)
Health Concerns, food supplement from the US market
Label withdrawn from the US market. Astra C (Health Concerns), a food supplement au code-barres 810034440099, is described by its US market label. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 1,140 mg a day according to the label (at most 3 servings a day), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Zinc: up to 60 mg a day according to the label (at most 3 servings a day), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- À vérifier
Zinc: up to 60 mg a day according to the label, above the tolerable upper intake level from EFSAEuropean Food Safety Authority. for adults (25 mg a day). The EFSA reference covers total daily intake, from food and supplements.
Source: EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), limite supérieure de sécurité (UL).
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Health Concerns
- Barcode
- 810034440099
- Form
- Capsule
- One serving
- 3 capsules
- Servings
- up to 3 servings per day
- Other ingredients (in English, as written)
- Hypromellose, Rice Bran
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Vitamin C | Vitamin | 380 mg |
| Zinc | Mineral | 20 mg |
| Proprietary Herbal Blend | Blend | 855 mg |
| Astragalus root extract (Astragalus membranaceus) | Plant | not stated |
| Bai-zhu Atractylodes | Plant | not stated |
| Rose Hips (Rosa canina) | Plant | not stated |
| Acerola | Plant | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Astra C
Entered into DSLD on 25 April 2017. On sale on the US market (according to the DSLD).- Active ingredient added : Astragalus (quantity not stated)
- Active ingredient added : Blend (Herb/Botanical) (400 mg)
- Active ingredient added : Proprietary Blend (660 mg)
- Active ingredient added : Siler (quantity not stated)
- Active ingredient added : White Atractylodes (quantity not stated)
- Active ingredient added : Zinc Citrate (10 mg)
- Active ingredient removed : Astragalus root extract (quantity not stated)
- Active ingredient removed : Bai-zhu Atractylodes (quantity not stated)
- Active ingredient removed : Proprietary Herbal Blend (855 mg)
- Active ingredient removed : Zinc (20 mg)
- Different quantity per serving : Vitamin C: 250 mg in this version; 380 mg on the displayed label
Official label: Astra C
Entered into DSLD on 25 June 2013. Withdrawn from the US market on 21 March 2017 (according to the DSLD).- Active ingredient added : Astragalus (quantity not stated)
- Active ingredient added : Proprietary Blend (400 mg. per tablet) of: (1,320 mg)
- Active ingredient added : Siler (quantity not stated)
- Active ingredient added : White Atractylodes (quantity not stated)
- Active ingredient added : Zinc Citrate (10 mg)
- Active ingredient removed : Astragalus root extract (quantity not stated)
- Active ingredient removed : Bai-zhu Atractylodes (quantity not stated)
- Active ingredient removed : Proprietary Herbal Blend (855 mg)
- Active ingredient removed : Zinc (20 mg)
- Different quantity per serving : Vitamin C: 250 mg in this version; 380 mg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Astragalus root extract
Read the warning, when it applies and the studies cited
ASTRAGALUS - ASTRAGALUS MEMBRANACEUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Astragalus Root. Santa Cruz (CA): American Herbal Pharmacopoeia; 1999.
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).
Sources cited by Health Canada (2)
- Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
- Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Health Concerns
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Astra C : étiquette retirée du marché américain (Health Concerns): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/810034440099-astra-c-health-concerns, updated 7 August 2025.